Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Oleg V. Ardashov is active.

Publication


Featured researches published by Oleg V. Ardashov.


Journal of Medicinal Chemistry | 2011

Highly potent activity of (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in animal models of Parkinson's disease.

Oleg V. Ardashov; Alla Pavlova; Irina Il’ina; Ekaterina A. Morozova; D. V. Korchagina; Elena V. Karpova; K. P. Volcho; Tat’yana Tolstikova; N. F. Salakhutdinov

(1R,2R,6S)-3-Methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol 1 possesses potent antiparkinsonian activity in both MPTP and haloperidol animal models. The use of compound 1 resulted in nearly full recovery of the locomotor and exploratory activities and was as effective as the comparator agent (levodopa). All eight stereoisomers of compound 1 have been synthesized and the influence of the absolute configuration on the antiparkinsonian activity of compound 1 was shown.


Materials | 2013

Selective Preparation of trans-Carveol over Ceria Supported Mesoporous Materials MCM-41 and SBA-15

Martina Stekrova; N. Kumar; Päivi Mäki-Arvela; Oleg V. Ardashov; K. P. Volcho; N. F. Salakhutdinov; Dmitry Yu. Murzin

Ce-modified mesoporous silica materials MCM-41 and SBA-15, namely 32 wt % Ce–Si–MCM-41, 16 wt % Ce–H–MCM-41 and 20 wt % Ce–Si–SBA-15, were prepared, characterized and studied in the selective preparation of trans-carveol by α-pinene oxide isomerization. The characterizations of these catalysts were performed using scanning electron microscopy, X-ray photoelectron spectroscopy, nitrogen adsorption and FTIR pyridine adsorption. Selective preparation of trans-carveol was carried out in the liquid phase in a batch reactor. The activity and the selectivity of catalyst were observed to be influenced by their acidity, basicity and morphology of the mesoporous materials. The formation of trans-carveol is moreover strongly influenced by the basicity of the used solvent and in order to achieve high yields of this desired alcohol it is necessary to use polar basic solvent.


Letters in Drug Design & Discovery | 2011

Antiviral Activity of 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol and its Derivatives Against Influenza A(H1N1)2009 Virus

Oleg V. Ardashov; Vladimir V. Zarubaev; Anna A. Shtro; D. V. Korchagina; K. P. Volcho; N. F. Salakhutdinov; Oleg I. Kiselev

A number of new derivatives of monoterpenoid with a para-menthane framework 3-methyl-6-(prop-1-en-2- yl)cyclohex-3-ene-1,2-diol (-)-3 were synthesized. The antiviral activity of (-)-3 and its derivatives against the pandemic influenza virus A/California/07/09 (H1N1)v was studied in vitro. Compound (-)-3 was found to be active against this vi- rus (selectivity index 7.5); for mononicotinate (+)-6 the selectivity index was 17. The absolute configuration of compound 6 was shown to be critical for its antiviral activity.


Medicinal Chemistry | 2013

3-Methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol: the Importance of Functional Groups for Antiparkinsonian Activity

Oleg V. Ardashov; Alla Pavlova; D. V. Korchagina; K. P. Volcho; Tat’yana Tolstikova; N. F. Salakhutdinov

Compounds with different sets of three of the four functional groups of (1R,2R,6S)-3-methyl-6-(prop-1-en-2- yl)cyclohex-3-ene-1,2-diol 1 possessing high antiparkinsonian activity were synthesized. The synthesized compounds were tested for the antiparkinsonian activity in vivo on a mouse model with MPTP neurotoxin. A pronounced antiparkinsonian effect of 1 can only be achieved if it contains all the four functional groups (two hydroxy groups and two double bonds). The 2-hydroxy group or the 3,4-double bond is not required for stimulating the exploratory activity of the animals.


Russian Journal of Organic Chemistry | 2009

Unusual products of the reactions of verbenone and verbenol with N-bromosuccinimide in the presence of water

Oleg V. Ardashov; I. V. Il’ina; D. V. Korchagina; K. P. Volcho; N. F. Salakhutdinov

The major products of the reactions of (−)-verbenone and (+)-trans-verbenol with N-bromosuccinimide in the presence of water were compounds having an oxabicyclo[3.2.1]octane skeleton but containing different numbers of bromine atoms in their molecules.


Marmara Pharmaceutical Journal | 2017

The action of monoterpenoids with promising antiparkinsonian activity on fertility of Drosophila melanogaster

Raisa G. Khamidullina; Oleg V. Ardashov; K. P. Volcho; N. F. Salakhutdinov; Maxim V. Trushin

Adequate treatment of Parkinson’s disease is an important medical issue. Patients are suffered from numerous side effects of the widely used drugs. It has been found recently that monoterpenoid (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl) cyclohex-3-ene-1,2-diol and its diacetate demonstrate high antiparkinsonian activity in some animal models. At the same time, their genetic safety was not studied yet. The aim of this research was to investigate the effect of these compounds with antiparkinsonian activities on reproduction of D. melanogaster. Over 4000 of fruitflies cultivated under the action of these compounds were analyzed. It was found that the chemicals did not provoke genetic mutations or alter reproduction of D. melanogaster. The possible explanations for the detected phenomena are provided. It was found that the compounds do not affect fertility in Drosophila..


Mendeleev Communications | 2007

Unusual α-hydroxyaldehyde with a cyclopentane framework from verbenol epoxide

Oleg V. Ardashov; Irina Il’ina; D. V. Korchagina; K. P. Volcho; N. F. Salakhutdinov


Archive | 2010

Agent for treating Parkinson's disease

Nariman Faridovich Salahutdinov; Tatiana Genrihovna Tolstikova; Alla Pavlova; Ekaterina A. Morozova; Irina V. Il'ina; Oleg V. Ardashov; K. P. Volcho


Helvetica Chimica Acta | 2015

The First Synthesis of (4S,5R,6R)‐5,6‐Dihydroxy‐4‐(prop‐1‐en‐2‐yl)cyclohex‐1‐ene‐1‐carboxylic Acid

Oleg V. Ardashov; Yuliya S. Demidova; D. V. Korchagina; K.P. Volcho; Irina L. Simakova; N.F. Salakhutdinov


Archive | 2016

3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-3-ENE-1,2,-DIOL EPOXIDES, NOVEL ANTI-PARKINSON'S AND ANTISPASMODIC DRUGS

Oleg V. Ardashov; Олег Васильевич Ардашов; Alla Pavlova; Алла Викторовна Павлова; D. V. Korchagina; Дина Владимировна Корчагина; Tatiana Genrihovna Tolstikova; Татьяна Генриховна Толстикова; K. P. Volcho; Константин Петрович Волчо; N. F. Salakhutdinov; Нариман Фаридович Салахутдинов

Collaboration


Dive into the Oleg V. Ardashov's collaboration.

Top Co-Authors

Avatar

K. P. Volcho

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. V. Korchagina

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Alla Pavlova

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Irina Il’ina

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Elena V. Karpova

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

I. V. Il’ina

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Irina L. Simakova

Novosibirsk State University

View shared research outputs
Researchain Logo
Decentralizing Knowledge